Platelet-derived nanomedicine targets cancer

5Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In this issue of Blood, Michael et al report that microparticles produced by platelets can infiltrate tumors outside the vasculature. Microparticles transfer their microRNA cargo to tumor cells, which triggers apoptosis and thereby reduces tumor growth.1 This study highlights a novel role of platelets, via their microparticles, in tumor pathogenesis.

Cite

CITATION STYLE

APA

Boilard, E. (2017, August 3). Platelet-derived nanomedicine targets cancer. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2017-05-786327

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free